Zhongheng Group (600252.SH) plans to transfer 23.43% of Laimei Pharmaceutical's shares

Zhitongcaijing · 11/26 11:25

Zhitong Finance App News, Zhongheng Group (600252.SH) issued an announcement that the company plans to transfer 247 million shares of Chongqing Laimei Pharmaceutical Co., Ltd. (“Laimei Pharmaceutical”) tradable A shares (accounting for 23.43% of the total share capital of Laimei Pharmaceuticals) held by the company through a public solicitation agreement. If the public offering and transfer of shares is completed, it may lead to changes in the controlling shareholders and actual controllers of Laimei Pharmaceutical.